相关实验视频
Updated: Jul 29, 2025
05:14
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
4.7K
PDE10A无活化可以防止多克索鲁比诱导的心脏毒性和瘤生长
Si Chen1, Jiawei Chen1,2,3, Wenting Du1,4
1Departments of Medicine (S.C., J.C., W.D., D.M.M., C.Y.), University of Rochester School of Medicine and Dentistry, Rochester, NY.
Circulation research
|May 26, 2023
概括
抑制PDE10A可以防止多克索鲁比辛的心脏毒性,并抑制癌症的生长. 这种固酶10A (PDE10A) 抑制为癌症患者提供了双重治疗策略,减少化疗副作用并提高治疗效率.
科学领域:
- 心血管生物学 心血管生物学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 循环核酸 (cAMP,cGMP) 在心血管健康和疾病中至关重要.
- 基化酶10A (PDE10A) 将cAMP和cGMP都进行水解.
- 在瘤中,PDE10A被上调,其抑制阻碍了癌细胞的生长.
研究的目的:
- 调查PDE10A在多克索鲁比 (DOX) 诱导的心脏毒性的作用.
- 评估PDE10A抑制对癌症进展和DOX心脏毒性的影响.
主要方法:
- 使用了PDE10A淘汰赛小鼠和抑制剂TP-10.
- 在小鼠模型中评估了DOX心脏毒性 (C57Bl/6J和卵巢癌异种移植).
- 在实验室中使用隔离心肌细胞和人类卵巢癌细胞进行的研究.
主要成果:
- 抑制/缺乏PDE10A减轻了DOX诱导的心肌损伤,亡和功能障碍.
- 抑制PDE10A降低了癌细胞活力,增殖,并增强了DOX效应.
- 在PDE10A抑制的异种移植模型中,瘤生长减弱,心脏毒性降低.
- 从机制上讲,PDE10A通过Top2β,线粒体功能障碍和DNA损伤促进DOX心脏毒性,同时通过FoxO3信号传输促进缩.
结论:
- PDE10A在DOX诱导的心脏毒性和癌症生长中起着重要作用.
- 抑制PDE10A是一种有前途的治疗策略,用于癌症治疗.
- 向PDE10A可能有双重好处:预防心脏毒性和抑制瘤进展.
相关概念视频
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.6K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.6K
01:26Heart Failure Drugs: Inotropic Agents
645
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
645
02:38Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K